Home/Filings/4/0001209191-04-008646
4//SEC Filing

DARLING ALLAN JAMES 4

Accession 0001209191-04-008646

CIK 0001036629other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 3:05 PM ET

Size

9.0 KB

Accession

0001209191-04-008646

Insider Transaction Report

Form 4
Period: 2004-02-06
DARLING ALLAN JAMES
VP, US Biologics Testing
Transactions
  • Disposition from Tender

    Common Stock

    2004-02-06$48.00/sh287$13,7760 total

Issuer

BIORELIANCE CORP

CIK 0001036629

Entity typeother

Related Parties

1
  • filerCIK 0001255093

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 3:05 PM ET
Size
9.0 KB